Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition: Short report

European Journal of Cancer Care

Volumn 16, Issue 3, 2007, Pages 289-290

  Douzenis, A ^a   Michopoulos, I ^a   Economopoulos, T ^a   Lykouras, L ^a   Soldatos, C R ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Agitation; Alprazolam; Parenteral nutrition; Sublingual olanzapine

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; OLANZAPINE;

ANXIETY DISORDER; ARTICLE; CASE REPORT; HUMAN; HUMAN RELATION; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; STOMACH TUMOR; SUBLINGUAL DRUG ADMINISTRATION; TERMINALLY ILL PATIENT;

ADMINISTRATION, SUBLINGUAL; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE; STOMACH NEOPLASMS; TERMINALLY ILL;

EID: 34248575440     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00735.x     Document Type: Article

References (10)

1. Davis M.P. Dickerson E.D. (2001) Olanzapine: another psychotropic? American Journal of Hospital Palliative Care 18, 129 132.
2. Davis M.P., Khawam E., Pozuelo L. Lagman R. (2002) Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project. Expert Review of Anticancer Therapy 2, 365 376.
3. Davis J.M., Chen N. Glick I.D. (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry 60, 553 564.
4. Duggan L., Fenton M., Dardennes R.M., El-Dosoky A. Indran S. (2005) Olanzapine for Schizophrenia [Cochrane Review on CD-ROM]. Cochrane Library, Update Software; issue 2, Oxford, England.
5. Garzone P.D. Kroboth P.D. (1989) Pharmacokinetics of the newer benzodiazepines. Clinical Pharmacokinetics 16, 337 364.
6. Goodnick P.J. Barrios C.A. (2001) Use of olanzapine in non-psychotic psychiatric disorders. Expert Opinions in Pharmacotherapy 2, 667 680.
7. Sadock B. Sadock V. (2001) Benzodiazepines. In : Pocket Handbook of Psychiatric Drug Treatment, 3rd edn (eds Sadock B.J. Sadock V.A. pp. 63 74, 204 218. Williams & Wilkins, Philadelphia, PA, USA.
8. Scavone J.M., Greenblatt D.J. Shader R.I. (1987) Alprazolam kinetics following sublingual and oral administration. Journal of Clinical Psychopharmacology 7, 332 334.
9. Scavone J.M., Greenblatt D.J., Goddard J.E., Friedman H., Harmatz J.S. Shader R.I. (1992) The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state. European Journal of Clinical Pharmacology 42, 439 443.
10. Wald A. (1999) Irritable bowel syndrome. Current Treatment Options in Gastroenterology 2, 13 19.